CeriBell Inc
CBLL11.584USD
+0.144+1.26%
Market hours （ET）Quotes delayed by 15 min
423.99MMarket Cap
LossP/E TTM
More Details of CeriBell Inc Company
Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
Company Info
Ticker SymbolCBLL
Company nameCeribell Inc
IPO dateOct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Number of employees281
Security typeOrdinary Share
Fiscal year-endOct 11
Address360 N. Pastoria Avenue
CitySUNNYVALE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94085
Phone18004360826
Websitehttps://ceribell.com/
Ticker SymbolCBLL
IPO dateOct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-0.27%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
+4.31%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-0.27%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
+4.31%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2023
FY2022
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
By RegionUSD
Name
Revenue
Proportion
United States
20.49M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
Shareholding Stats
Updated: Mon, Sep 8
Updated: Mon, Sep 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Other
56.52%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Other
56.52%
Shareholder Types
Shareholders
Proportion
Investment Advisor
41.33%
Investment Advisor/Hedge Fund
18.68%
Private Equity
10.82%
Individual Investor
10.46%
Venture Capital
9.21%
Hedge Fund
2.82%
Research Firm
0.96%
Pension Fund
0.28%
Bank and Trust
0.19%
Other
5.26%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
162
33.13M
90.36%
+3.75M
2025Q1
157
34.07M
94.45%
+6.99M
2024Q4
111
32.79M
91.42%
+9.94M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.75M
13.15%
-38.89K
-0.81%
Mar 31, 2025
TPG Capital, L.P.
3.97M
10.98%
--
--
Mar 31, 2025
Longitude Capital Management Co., LLC
2.48M
6.85%
+2.48M
--
Oct 16, 2024
Ally Bridge Group (HK) Limited
2.18M
6.02%
-134.10K
-5.80%
Apr 11, 2025
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.55%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.1%
--
--
Mar 31, 2025
Parvizi (Josef)
2.09M
5.78%
+6.62K
+0.32%
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
782.72K
2.17%
+78.31K
+11.12%
Mar 31, 2025
The Vanguard Group, Inc.
693.83K
1.92%
-2.26K
-0.32%
Mar 31, 2025
Chao (Xingjuan)
1.05M
2.92%
--
--
Jun 03, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.55%
Hypatia Women CEO ETF
0.45%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0%
FlexShares Morningstar US Market Factor Tilt Index Fund
0%
iShares Morningstar Small-Cap ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Neuroscience and Healthcare ETF
Proportion0.55%
Hypatia Women CEO ETF
Proportion0.45%
ProShares Hedge Replication ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Franklin US Small Cap Multifactor Index ETF
Proportion0%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proportion0%
iShares Morningstar Small-Cap ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
